Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd share price ticked higher by 4.50% to Rs 576.1 after the company's net profit plunged by 60.33% to Rs 16.55 crore, while revenue from operations gained significantly 22.29% to Rs 235.53 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 74333.63 crore, improving 10.36%. It has eased by 0.23% over last one week and climbed by 12.68% in last one month while the market capitalization of Krsnaa Diagnostics Ltd has inched up 1.57% and 1.81% in the same period respectively. Profit before tax (PBT) of Krsnaa Diagnostics Ltd stood at Rs 22.44 crore in Q2 FY26, crashing by 18.16% year-on-year, and nosediving by 56.60% quarter-on-quarter. EBITDA came in at Rs 51 crore, gaining 6.98% YoY and expanding by 117.07% sequentially. Total expenses surged 28.20% to Rs 205.51 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 50.19 crore, going up by 13.12% YoY, while employee benefits expense was at Rs 36.06 crore, improving by 8.13% YoY. For the TTM ended FY26, revenue from operations advanced 15.74% to Rs 717.16 crore, while net profit surged by 36.54% to Rs 77.61 crore, compared to previous TTM. EBITDA jumped by 14022% to Rs 164.58 crore, and PBT jumped 46.68% to Rs 102.69 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 87.33 crore in FY26, as against Rs 24.35 crore in FY25. Krsnaa Diagnostics Ltd nosedived by 27.10% in last one year, underperforming the benchmark BSE Sensex which has eased by 3.21% during the same period.

Krsnaa Diagnostics Ltd share price softened by 4.01% to Rs 551.3 after the company's net profit tumbled by 60.33% to Rs 16.55 crore, while revenue from operations gained significantly 22.29% to Rs 235.53 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 73454.32 crore, advancing by 10.70%. It has marginally improved by 2.40% over last one week and jumped by 15.08% in last one month while the market capitalization of Krsnaa Diagnostics Ltd has slipped by 2.36% and 5.43% in the same period respectively. Profit before tax (PBT) of Krsnaa Diagnostics Ltd stood at Rs 22.44 crore in Q2 FY26, tanking 18.16% year-on-year, and crashing by 56.60% quarter-on-quarter. EBITDA came in at Rs 51 crore, gaining 6.98% YoY and expanding by 117.07% sequentially. Total expenses jumped by 28.20% to Rs 205.51 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 50.19 crore, rising 13.12% YoY, while employee benefits expense was at Rs 36.06 crore, improving by 8.13% YoY. For the TTM ended FY26, revenue from operations grew 15.74% to Rs 717.16 crore, while net profit saw a strong growth of 36.54% to Rs 77.61 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 14022% to Rs 164.58 crore, and PBT jumped 46.68% to Rs 102.69 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 87.33 crore in FY26, as against Rs 24.35 crore in FY25. Krsnaa Diagnostics Ltd plunged by 30.98% in last one year, underperforming the benchmark BSE Sensex which has softened by 3.05% during the same period.

Revenue from operations jumped by 3.5% year-on-year (YoY) to Rs 192.60 crore in the quarter ended 31 March 2026. Profit before tax in Q4 FY26 stood at Rs 51.70 crore, up by 80.71% from Rs 28.61 crore in Q4 FY25. On a full-year basis, the company's consolidated net profit jumped 30.69% to Rs 101.43 crore on a 7.75% rise in net sales to Rs 772.77 crore in FY26 over FY25. Mitesh Dave, Group CEO, said, 'FY2026 represents a pivotal inflection point in Krsnaa Diagnostics' growth journey, marked not only by strong headline financial performance but more significantly by the accelerated emergence of our retail diagnostics vertical, Krsnaa Retail, as a structurally important and independently scalable growth engine for the group. Within just twelve months of focused scaling, our retail vertical delivered an 8 times jump in revenue and a 7 times surge in touchpoints, expanding to 3,500 locations across 5 states, a pace of growth that firmly establishes Krsnaa Retail as one of the country's most formidable retail diagnostics growth stories. As we enter FY2027, we remain focused on disciplined execution, transparency, and strong governance standards while continuing to uphold the trust placed in us by our investors, partners, and patients. The company has recommended a final dividend of Rs 2 per equity share of face value Rs 5 each (40% of face value) for FY26, subject to shareholders' approval at the ensuing AGM. Krsnaa Diagnostics is an integrated diagnostics service provider in India, offering technology-enabled diagnostic services including radiology, pathology, tele-radiology, and clinical laboratory services to public and private healthcare institutions across the country. Shares of Krsnaa Diagnostics shed 0.27% to Rs 553.65 on the BSE.Powered by Capital Market - Live

Krsnaa Diagnostics announced that the Board of Directors of the Company at its meeting held on 25 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 40%) , subject to the approval of the shareholders.

Net profit of Krsnaa Diagnostics rose 101.74% to Rs 41.72 crore in the quarter ended March 2026 as against Rs 20.68 crore during the previous quarter ended March 2025. Sales rose 3.50% to Rs 192.60 crore in the quarter ended March 2026 as against Rs 186.08 crore during the previous quarter ended March 2025. For the full year,net profit rose 30.69% to Rs 101.43 crore in the year ended March 2026 as against Rs 77.61 crore during the previous year ended March 2025. Sales rose 7.75% to Rs 772.77 crore in the year ended March 2026 as against Rs 717.16 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales192.60186.08 4 772.77717.16 8 OPM %28.4928.47 -27.4126.51 - PBDT74.2950.56 47 220.83191.01 16 PBT51.7028.61 81 130.37102.69 27 NP41.7220.68 102 101.4377.61 31 Powered by Capital Market - Live

Krsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 25 May 2026.

Net profit of Krsnaa Diagnostics declined 21.47% to Rs 15.25 crore in the quarter ended December 2025 as against Rs 19.42 crore during the previous quarter ended December 2024. Sales rose 3.83% to Rs 181.20 crore in the quarter ended December 2025 as against Rs 174.51 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales181.20174.51 4 OPM %25.5825.83 - PBDT42.3448.18 -12 PBT19.6825.48 -23 NP15.2519.42 -21 Powered by Capital Market - Live

Net profit of Krsnaa Diagnostics declined 23.66% to Rs 16.49 crore in the quarter ended December 2025 as against Rs 21.60 crore during the previous quarter ended December 2024. Sales declined 3.47% to Rs 159.43 crore in the quarter ended December 2025 as against Rs 165.16 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales159.43165.16 -3 OPM %29.9029.00 - PBDT43.7551.06 -14 PBT21.2228.37 -25 NP16.4921.60 -24 Powered by Capital Market - Live

Krsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live

Krsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 12 December 2025.Powered by Capital Market - Live